A Phase 3, Randomized, Masked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the Treatment of Subjects With Macular Edema Associated With Non-infectious Uveitis

Trial Profile

A Phase 3, Randomized, Masked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the Treatment of Subjects With Macular Edema Associated With Non-infectious Uveitis

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Apr 2018

At a glance

  • Drugs Triamcinolone (Primary)
  • Indications Panuveitis; Uveitis
  • Focus Registrational; Therapeutic Use
  • Acronyms PEACHTREE
  • Sponsors Clearside Biomedical
  • Most Recent Events

    • 27 Mar 2018 Status changed from active, no longer recruiting to completed.
    • 05 Mar 2018 According to a Clearside Biomedical media release, detailed results from PEACHTREE will be presented at an upcoming medical conference.
    • 05 Mar 2018 Results presented in a Clearside Biomedical media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top